|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | (2006.01) |
| A61K 31/00 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/19 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/175 | (2013.01) | ||
| A61K 31/17 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 31/175 | (2006.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3218061 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15859861.5 |
| Date of filing the European patent application | 2015-11-11 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/060052 |
| Date | 2015-11-11 |
| (87) | Number | WO 2016/077406 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462080091 P | 2014-11-14 | US | |
| 201514936227 | 2015-11-09 | US |
| (72) |
PATEL, Mahendra R. , US
|
| (73) |
Navinta III Inc ,
1003 Clint Moore Road, Boca Raton, FL 33487,
US
|
| (54) | CARMUSTINE PHARMACEUTICAL COMPOSITION |
| CARMUSTINE PHARMACEUTICAL COMPOSITION |